Related Experiment Videos
Serologic testing for Lyme disease
1Connecticut Agricultural Experiment Station, New Haven 06504.
Postgraduate Medicine
|May 1, 1990
Summary
Diagnosing Lyme disease relies on antibody tests, but early stages may show undetectable IgM. Serologic results require clinical correlation due to potential false positives and residual antibodies.
Area of Science:
- Infectious Diseases
- Immunology
- Medical Diagnostics
Background:
- Serologic testing is the primary method for diagnosing Borrelia burgdorferi infection.
- Early Lyme disease (within 6 weeks) may not have detectable specific IgM antibodies.
- Current confirmatory methods like Western blot are laborious and costly.
Purpose of the Study:
- To highlight the limitations of serologic testing for Borrelia burgdorferi infection.
- To emphasize the importance of interpreting serologic results alongside clinical data.
Main Methods:
- Review of current diagnostic practices for Lyme disease.
- Discussion of serologic antibody detection methods (IgM, IgG).
- Consideration of Western blot, indirect fluorescent antibody staining, and enzyme-linked immunosorbent assay.
Main Results:
- Specific IgM antibodies may be undetectable in early Lyme disease.
- Cross-reactivity can lead to false-positive results.
- Residual antibodies from prior subclinical infection can complicate interpretation.
Conclusions:
- Serologic test results for Borrelia burgdorferi must be interpreted cautiously.
- Clinical and epidemiologic findings are crucial for accurate Lyme disease diagnosis.
- Limitations of current antibody assays necessitate a comprehensive diagnostic approach.